Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LCOWD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
MRG-004A
|
|||||
| Synonyms |
MRG 004A; MRG004A
Click to Show/Hide
|
|||||
| Organization |
Shanghai Miracogen Inc.; Lepu Biopharma Co., Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tissue factor (F3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Site-specific conjugation through the glycan remodeling and click chemistry at Asn297.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.